Overview
The Wolverine Blend.
Two of the most popular healing peptides pre-mixed in one vial.
What It Does
Wolverine Blend (BPC-157 + TB-500) – pre-mixed healing blend: BPC-157 (local repair + angiogenesis) + TB-500 (systemic actin modul BPC-157 activates VEGF/NO/GHR pathways for local tissue repair.
Painkillers vs this Painkillers only mask pain; this blend aims to rebuild the tissue. Skip NSAIDs (ibuprofen, Advil, Aleve, aspirin) during a cycle; they slow healing on their own; if you need pain relief, Tylenol is the better pairing. The old belief that NSAIDs “cancel out” the blend is a myth. Honest caveat: the healing evidence is still mostly from animals, not human trials.
Reconstitution
| Vial Size | BAC Water / Solvent | Concentration |
|---|---|---|
| 10 mg | + 1 mL | 10 mg/mL |
| 20 mg | + 2 mL | 10 mg/mL |
| 30 mg | + 3 mL | 10 mg/mL |
Reconstitution Calculator
Enter the vial amount and diluent volume to calculate concentration. If you already have a target amount, you can also convert it to liquid volume and syringe markings. This tool does not recommend a target amount.
Enter a target amount you already have and select the syringe capacity.
Mathematical reference only. The calculator does not determine an appropriate target amount. Syringe capacity only changes the maximum volume that fits.
Protocol
| Phase | Frequency | Amount | Notes |
|---|---|---|---|
| Weeks 1–2 | Daily | 500 | Loading: assess tolerance. Daily because BPC-157’s serum half-life is short (~30 min); TB-500 rides along in |
| Weeks 3–4 | Daily | 750 | Step up only if Weeks 1–2 well tolerated. Half-unit step is optional – many users go directly to 1 mg. |
| Weeks 5–10 | Daily AM | 1 mg | Working dose. Once daily preferred; optional AM/PM split (5u + 5u) if you find injection volume uncomfortable. |
| Aggressive | Twice daily (AM + | 1 mg | For acute injury, post-surgical recovery, or a stalled response. 1 mg blend twice daily = 1 mg of each |
| Off | 2–4 weeks | – | Standard washout. Re-cycle if continued tissue work needed. |
8–10 weeks on / 2–4 weeks off (daily microdose). Aggressive (twice daily, acute injury): 4–6 weeks split-dose / 4 weeks off, then back to daily working dose.
Daily, anytime; Wolverine Blend; food doesn’t affect
Unisex (BPC-157 + TB-500 recovery), same protocol for men and women, no cycle effect. Avoid in pregnancy.
Handling & Stacking
- Faster recovery than either alone.
- Pain reduction within days, structural repair over 4–12 weeks.
- Systemic anti-inflammatory effect complements localised healing.
- Supply math 10mg → 6 vials | 20mg → 3 vials | 30mg → 2 vials (10-wk @ 1 mg × 7/wk)
- NSAIDs during a repair cycle (ibuprofen/Advil/Aleve slow healing on their own; use Tylenol for pain).
- Active malignancy.
- High-dose vitamin C same session.
- GLOW / KLOW Blend (already contains BPC + TB – would double-dose)
Safety & Patient Education
- Active or suspected malignancy.
- TB-500 is angiogenic systemically, BPC-157 drives angiogenesis locally via VEGF.
- Theoretical, but neither can tell healthy tissue from a tumour you don’t know about.
- Screen age-appropriately before a long run; stop for any new lump.
- Active bleeding or recent hemorrhagic stroke (TB-500 vascular) Pregnancy, lactation
- Two-peptide stack, any single-component contraindication applies.
- Active cancer is an absolute stop Both are research peptides without published human RCTs.
- All use is off-label; quality varies Local injection near target tissue for orthopedic use; SubQ near abdomen for systemic.
- Rotate sites Cycle: 4–6 wks on / 2–4 wks off.
- Continuous dosing isn’t supported and may blunt response
